XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Millions
 3 Months Ended 6 Months Ended
Mar. 26, 2022
Mar. 27, 2021
Mar. 26, 2022
Mar. 27, 2021
Revenues:        
Product $ 1,268.2 $ 1,378.8 $ 2,571.6 $ 2,834.2
Service and other 167.5 158.8 335.3 313.2
Revenues 1,435.7 1,537.6 2,906.9 3,147.4
Costs of revenues:        
Product 322.6 300.7 640.7 585.2
Amortization, Cost of Goods Sold 72.3 64.5 147.2 126.1
Service and other 94.2 86.6 186.1 170.0
Gross profit 946.6 1,085.8 1,932.9 2,266.1
Operating expenses:        
Research and development 69.5 71.5 142.3 130.7
Selling and marketing 171.4 131.5 318.7 259.5
General and administrative 100.5 88.9 218.5 180.4
Amortization of acquired intangible assets 11.3 10.2 22.1 20.4
Contingent consideration fair value adjustments 0.0 (14.7) (4.1) (10.1)
Restructuring and divestiture charges (0.2) 1.6 0.0 3.0
Operating expenses 352.5 289.0 697.5 583.9
Income from operations 594.1 796.8 1,235.4 1,682.2
Interest income 0.8 0.3 1.2 0.7
Interest expense (22.6) (21.3) (48.3) (49.3)
Debt extinguishment loss 0.0 0.0 (0.7) (21.6)
Other income, net 2.1 4.7 8.7 0.9
Income before income taxes 574.4 780.5 1,196.3 1,612.9
Provision for income taxes 118.7 161.1 241.4 340.1
Net income 455.7 619.4 954.9 1,272.8
Net loss attributable to noncontrolling interest 0.0 (0.5) 0.0 (1.5)
Net income attributable to Hologic $ 455.7 $ 619.9 $ 954.9 $ 1,274.3
Net income per common share attributable to Hologic:        
Basic (in usd per share) $ 1.81 $ 2.40 $ 3.78 $ 4.93
Diluted (in usd per share) $ 1.80 $ 2.38 $ 3.75 $ 4.88
Weighted average number of shares outstanding:        
Basic (in shares) 251,574 258,473 252,537 258,539
Diluted (in shares) 253,658 260,749 254,864 261,267